A Study to Evaluate the Safety and Tolerability of Subcutaneous Treprostinil and Pharmacokinetics of a Novel LY900014 Formulation in Healthy Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Insulin lispro (Primary) ; Treprostinil (Primary)
- Indications Pulmonary arterial hypertension; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eli Lilly
- 29 Jul 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 20 May 2016 Status changed from not yet recruiting to recruiting.